Patents Represented by Attorney Blanchard & Associates
  • Patent number: 8317988
    Abstract: The present invention relates to improved electrochemical biosensor strips and methods for determining the concentration of an analyte in a sample. By selectively measuring a measurable species residing in a diffusion barrier layer, to the substantial exclusion of the measurable species residing exterior to the diffusion barrier layer, measurement errors introduced by sample constituents, such as red blood cells, and manufacturing variances may be reduced.
    Type: Grant
    Filed: April 11, 2007
    Date of Patent: November 27, 2012
    Assignee: Bayer HealthCare LLC
    Inventor: Huan-Ping Wu
  • Patent number: 8308940
    Abstract: Provided are chromatography devices having a stationary phase that includes patchy particles having at least two different surface chemistries, such as Janus particles. Also provided are methods of separating at least one analyte out of a sample, where the method includes adding a sample having at least one analyte to a chromatography device that includes a stationary phase that includes a plurality of patchy particles. Further provided are methods that include packing a chromatography column with a plurality patchy particles having at least two different surface chemistries. Additional embodiments are disclosed.
    Type: Grant
    Filed: November 20, 2008
    Date of Patent: November 13, 2012
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Steve Granick, Liang Hong
  • Patent number: 8287717
    Abstract: The present invention relates to systems, methods, and devices for determining the concentration of an analyte in a sample. The use of linear, cyclic, or acyclic voltammetric scans and/or semi-integral, derivative, or semi-derivative data treatment may provide for increased accuracy when determining the concentration of an analyte in a sample. Hematocrit compensation in combination with the data treatments may reduce the hematocrit effect with regard to a glucose analysis in whole blood. In another aspect, fast scan rates may reduce the hematocrit effect.
    Type: Grant
    Filed: May 16, 2005
    Date of Patent: October 16, 2012
    Assignee: Bayer HealthCare LLC
    Inventor: Huan-Ping Wu
  • Patent number: 8283347
    Abstract: A non-leaching mediator may include a compound having the general formula (I): and salts thereof, where n is about 9, and X is a halogen; a compound having the general formula (II): and salts thereof, where n is about 9, and X is a halogen; and/or a compound, having the general formula (III): and salts thereof, where n is about 8, and X is a halogen.
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: October 9, 2012
    Assignee: Bayer HealthCare LLC
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green
  • Patent number: 8262899
    Abstract: A sensor system including devices and methods for determining the concentration of an analyte in a sample is described. Input signals including amperometric and voltammetric duty cycles of excitations and relaxations may provide a shorter analysis time and/or improve the accuracy and/or precision of the analysis. The disclosed system may reduce analysis errors, thus improving measurement performance, by adjusting the potential and/or scan rate in response to output currents obtained from voltammetric scans. The disclosed system also may determine the concentration of more than one ionizable species in the sample by adjusting the potential and/or scan rate in response to output currents obtained from voltammetric scans. The multiple, determined concentrations may be used to determine the concentration of multiple analytes or to correct the concentration determined for an analyte, thus improving the measurement performance of the system.
    Type: Grant
    Filed: July 10, 2009
    Date of Patent: September 11, 2012
    Assignee: Bayer HealthCare LLC
    Inventor: Huan-Ping Wu
  • Patent number: 8252523
    Abstract: A reagent composition for a biosensor sensor strip is disclosed that provides for rapid rehydration after drying. The composition includes porous particles and is preferably formed as a colloidal suspension. The dried reagent composition including porous particles may provide analytically useful output from the sensor strip in a shorter time period than observed from dried reagent compositions using solid particles. The output signal from the porous particle compositions may be correlated to the analyte concentration of a sample within about two seconds. In this manner, an accurate concentration determination of an analyte concentration in a sample may be obtained in less time than from sensor strips including conventional compositions. The reagent composition including the porous particles also may allow for the redox reaction between the reagents and the analyte to reach a maximum kinetic performance in a shorter time period than observed from conventional sensor strips.
    Type: Grant
    Filed: December 10, 2008
    Date of Patent: August 28, 2012
    Assignee: Bayer HealthCare LLC
    Inventor: Boru Zhu
  • Patent number: 8236914
    Abstract: A mechanochromic material includes a polymer having a backbone containing a mechanophore.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: August 7, 2012
    Assignee: Board of Trust of the University of Illinois
    Inventors: Stephanie L. Potisek, Douglas A. Davis, Scott R. White, Nancy R. Sottos, Jeffrey S. Moore
  • Patent number: 8234076
    Abstract: A biosensor has an abnormal output detection system that determines whether an output signal from the redox reaction of an analyte has a normal or abnormal shape or configuration. The abnormal output detection system improves the accuracy and precision of the biosensor in determining whether an output signal has a shape or configuration that may not provide an accurate and/or precise analysis of a biological fluid. The biosensor generates an output signal in response to the redox reaction of the analyte. The biosensor normalizes the output signal and compares the normalized output signal with one or more control limits. The biosensor may generate an error signal when the normalized output signal is not within the control limits.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: July 31, 2012
    Assignee: Bayer HealthCare LLC
    Inventors: Scott Carpenter, Christine D. Nelson, Huan-Ping Wu
  • Patent number: 8196928
    Abstract: A game is provided that simulates American style football. Action cards include offensive plays and defensive outcomes. Skill is introduced by the offensive play chosen by an offensive player. Chance is introduced by the defensive outcome corresponding to the offensive play selected by the offensive player. The game lacks dice, spinners, or other random number generators. The game includes one set of action cards, which are selected consecutively by the offensive player. As preferably listing only offensive plays, only the defensive outcomes, thus the results of the offensive plays, vary from card to card. The game includes a field with markers that may be used to track the progress of the game.
    Type: Grant
    Filed: October 18, 2010
    Date of Patent: June 12, 2012
    Assignee: StatoGames, Inc.
    Inventor: Nick T. Thomopoulos
  • Patent number: 8188302
    Abstract: A method includes reacting an amino group, a composition including rhodium and an organic ligand, and a substrate having structural formula (I) in a reaction mixture. R1 is an organic group including a sp3 carbon atom bonded to CA. R2 is selected from the group consisting of hydrogen, methyl, and an organic group including a sp3 carbon atom bonded to CA. R3 and R4 independently are selected from the group consisting of hydrogen, methyl, and an organic group including a sp3 carbon atom bonded to CB. The method further includes forming a hydroaminated product in the reaction mixture.
    Type: Grant
    Filed: October 14, 2008
    Date of Patent: May 29, 2012
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Zhijian Liu, John F. Hartwig
  • Patent number: 8147674
    Abstract: A sensor system, device, and methods for determining the concentration of an analyte in a sample is described. Input signals including multiple duty cycles of sequential excitation pulses and relaxations are input to the sample. One or more signals output from the sample within 300 ms of the input of an excitation pulse may be correlated with the analyte concentration of the sample to improve the accuracy and/or precision of the analysis. Determining the analyte concentration of the sample from these rapidly measured output values may reduce analysis errors arising from the hematocrit effect, mediator background, and other error sources.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: April 3, 2012
    Assignee: Bayer HealthCare LLC
    Inventor: Huan-Ping Wu
  • Patent number: 8148162
    Abstract: A biosensor system determines analyte concentration from an output signal generated by an oxidation/reduction reaction of the analyte. The biosensor system adjusts a correlation for determining analyte concentrations from output signals at one temperature to determining analyte concentrations from output signals at other temperatures. The temperature-adjusted correlation between analyte concentrations and output signals at a reference temperature may be used to determine analyte concentrations from output signals at a sample temperature.
    Type: Grant
    Filed: July 20, 2010
    Date of Patent: April 3, 2012
    Assignee: Bayer HealthCare LLC
    Inventors: Huan-Ping Wu, Christine D. Nelson
  • Patent number: 8026104
    Abstract: A biosensor system determines an analyte concentration of a biological sample using an electrochemical process without Cottrell decay. The biosensor system generates an output signal having a transient decay, where the output signal is not inversely proportional to the square root of the time. The transient decay is greater or less than the ?0.5 decay constant of a Cottrell decay. The transient decay may result from a relatively short incubation period, relatively small sample reservoir volumes, relatively small distances between electrode surfaces and the lid of the sensor strip, and/or relatively short excitations in relation to the average initial thickness of the reagent layer. The biosensor system determines the analyte concentration from the output signal having a transient decay.
    Type: Grant
    Filed: October 21, 2007
    Date of Patent: September 27, 2011
    Assignee: Bayer HealthCare LLC
    Inventors: Huan-Ping Wu, Steven C. Charlton, Amy H. Chu, Andrew J. Edelbrock, Sung-Kwon Jung, Dijia Huang
  • Patent number: 8007656
    Abstract: An electrochemical sensor strip has a base and a first electrode and a second electrode on the base. An oxidoreductase enzyme and a mediator are on the first electrode, and a soluble redox species is on the second electrode. The soluble redox species may be an organotransition metal complex, a transition metal coordination complex, an electroactive organic molecule, or mixtures thereof.
    Type: Grant
    Filed: October 22, 2004
    Date of Patent: August 30, 2011
    Assignee: Bayer HealthCare LLC
    Inventors: Huan-Ping Wu, Greg P. Beer, Christina Blaschke
  • Patent number: 8007024
    Abstract: A raisable truck bed cover protects the contents of the truck bed from the elements and theft, while allowing access to the contents when materials are placed on the cover. The raisable cover maintains the storage capability of the original truck design while allowing additional material hauling capacity by way of the cover and an optional ladder rack system.
    Type: Grant
    Filed: January 29, 2010
    Date of Patent: August 30, 2011
    Inventor: Jerry Kealy
  • Patent number: 7966859
    Abstract: A biosensor has an underfill detection system that determines whether a sample of a biological fluid is large enough for an analysis of one or more analytes. The underfill detection system applies an excitation signal to the sample, which generates an output signal in response to the excitation signal. The underfill detection system switches the amplitude of the excitation signal. The transition of the excitation signal to a different amplitude changes the output signal when the sample is not large enough for an accurate and/or precise analysis. The underfill detection system measures and compares the output signal with one or more underfill thresholds to determine whether an underfill condition exists.
    Type: Grant
    Filed: October 15, 2008
    Date of Patent: June 28, 2011
    Assignee: Bayer HealthCare LLC
    Inventors: Huan-Ping Wu, Christine D. Nelson
  • Patent number: 7862696
    Abstract: The present invention relates to electrochemical sensor strips and methods of determining the concentration of an analyte in a sample or improving the performance of a concentration determination. The electrochemical sensor strips may include at most 8 ?g/mm2 of a mediator. The strips, the strip reagent layer, or the methods may provide for the determination of a concentration value having at least one of a stability bias of less than ±10% after storage at 50° C. for 4 weeks when compared to a comparison strip stored at ?20° C. for 4 weeks, a hematocrit bias of less than ±10% for whole blood samples including from 20 to 60% hematocrit, and an intercept to slope ratio of at most 20 mg/dL. A method of increasing the performance of a quantitative analyte determination also is provided.
    Type: Grant
    Filed: September 10, 2007
    Date of Patent: January 4, 2011
    Assignee: Bayer HealthCare LLC
    Inventors: Huan-Ping Wu, Christine D. Nelson, Hope Spradlin, Eric Maurer
  • Patent number: 7829342
    Abstract: A composition including a complex of a metal, a tetradentate ligand, at least one ancillary ligand, and a counterion may be used for selective sp3 C—H bond oxidation. The tetradentate ligand may include a N-heterocyclic-N,N?-bis(pyridyl)-ethane-1,2-diamine group or a N,N?-bis(heterocyclic)-N,N?-bis(pyridyl)-ethane-1,2-diamine group. The composition can be used in combination with H2O2 to effect highly selective oxidations of unactivated sp3 C—H bonds over a broad range of substrates. The site of oxidation can be predicted, based on the electronic and/or steric environment of the C—H bond. In addition, the oxidation reaction does not require the presence of directing groups in the substrate.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: November 9, 2010
    Assignee: The Board of Trustees of the Universiy of Illinois
    Inventors: M. Christina White, Mark S. Chen
  • Patent number: D634394
    Type: Grant
    Filed: December 14, 2009
    Date of Patent: March 15, 2011
    Inventors: Daniel H. Whitman, Anastasios Karahalios, Andrew Burroughs
  • Patent number: D646348
    Type: Grant
    Filed: February 1, 2011
    Date of Patent: October 4, 2011
    Inventors: Daniel Whitman, Anastasios Karahalios, Andrew Burroughs